Navigation Links
Pharmacyclics Reports First Quarter Fiscal 2009 Financial Results
Date:10/30/2008

cly update any forward-looking statement, whether as a result of new information, future events or otherwise.

--- FINANCIALS ATTACHED ---

Pharmacyclics, Inc.

(a development stage enterprise)

Condensed Statements of Operations

(unaudited) (in thousands, except per share data)

Three Months Ended

30-Sep

2008 2007

Operating expenses:

Research and development $3,203 $5,240

General and administrative 3,439 2,067

Total operating expenses 6,642 7,307

Loss from operations (6,642) (7,307)

Interest and other, net 100 477

Net loss $(6,542) $(6,830)

Basic and diluted net loss per share $(0.25) $(0.26)

Shares used to compute basic and

diluted net loss per share 26,015 25,958

Condensed Balance Sheets

(unaudited, in thousands)

September 30, June 30,

2008 2008

Assets

Cash, cash equivalents and

marketable securities* $12,467 $16,755

Other current assets 560 401

Total current assets 13,027 17,156

Property and equipment, net 615 6
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results
2. Pharmacyclics Announces It Received Nasdaq Notice of Compliance
3. Pharmacyclics Announces It Received Nasdaq Notification
4. Pharmacyclics Announces Multiple Presentations at the American Association for Cancer Research Annual Meeting
5. Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008
6. Vanda Pharmaceuticals Reports Third Quarter 2008 Results
7. United Therapeutics Reports Third Quarter 2008 Financial Results
8. BioMed Realty Trust Reports Third Quarter 2008 Financial Results
9. Varian, Inc. Reports Strong Fourth Quarter 2008 Results
10. Sangamo BioSciences Reports Third Quarter 2008 Financial Results
11. VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 2013 This market report summarizes ... profiling carried out in May 2013. The full ... of the responses for each question, its segmentation ... also highlights some interesting differences, particularly between Pharma, ... models were developed to estimate the in house ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Quincy ... discovery and development of calcium-binding proteins to support ... safety assessment study of apoaequorin in ... journal published for the British Industrial Biological Research ... was to investigate potential adverse effects, if any, ...
(Date:5/23/2013)... -- BioScrip, Inc. (NASDAQ: BIOS ) today announced ... Global Healthcare Conference to be held June 3-6, 2013 ... Richard Smith , President and Chief Executive ... Financial Officer, will present on Monday, June 3, 2013 ... About BioScrip BioScrip, Inc. provides comprehensive infusion and ...
(Date:5/23/2013)... May 23, 2013 PuraMed BioScience ® ... marketer of over-the-counter (OTC) medicinal and healthcare products, ... on the company based on low market capitalization ... Non-Prescription, All Natural Product to Treat Migraine Headaches ... #1 Prescription Competitor , Currently Available Nationwide ...
Breaking Biology Technology:Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 2Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 3Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 4Safety Assessment Study of Apoaequorin Published in Food and Chemical Toxicology 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3
... , SUNNYVALE, Calif., Sept. 3 Pharmacyclics, ... on developing and commercializing innovative small molecule drugs for the ... Dr. Glenn Rice, President and COO, will provide a business ... -- Thomas Weisel Partners 2009 Healthcare Conference at the Four ...
... , NEW YORK, Sept. 3 Reportlinker.com announces ... , , Smart Glass: Technologies and ... , , This report: , ... overview of smart glass technology , Describes ...
... , , TONBRIDGE, ... are trapped in a postcode lottery after Department of Health (DH) ... over who is eligible for the jab. , , ... Health Authority (SHA) has advised all Primary Care Trusts (PCTs) in ...
Cached Biology Technology:Pharmacyclics to Present and Webcast at Upcoming Life Sciences Investor Conferences 2Reportlinker Adds Smart Glass: Technologies and Global Markets Report 2Reportlinker Adds Smart Glass: Technologies and Global Markets Report 3Health Workers Face Postcode Lottery for Swine Flu Vaccine, Chemist+Druggist Reveals 2
(Date:5/24/2013)... search for medication against Alzheimer,s disease, scientists have focused ... Amyloid beta (A-beta). After all, it is the accumulation of ... Alzheimer,s patients. Starting point for the formation of A-beta is ... first to unravel the function of APPL the fruit-fly ... flies. , Alessia Soldano (VIB/KU Leuven): "We have discovered ...
(Date:5/23/2013)... be the world,s most popular fruit, can be made ... purple GM varieties. , "Working with GM tomatoes ... addition of a specific compound, allows us to pinpoint ... Cathie Martin from the John Innes Centre. , The ... flavour, health and shelf life characteristics because even higher ...
(Date:5/23/2013)... at Rollins School of Public Health at Emory ... of Technology, have received a $4 million grant ... at Emory University (Health and Exposome Research Center: ... exposome-based center grant awarded in the United States. ... the National Institute of Environmental Health Sciences (NIEHS) ...
Breaking Biology News(10 mins):A new strategy required in the search for Alzheimer's drugs? 2The world's favorite fruit only better-tasting and longer-lasting 2Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3
... one in every 500 to 650 baby boys is born ... code that until a few years ago was thought to ... longer the case. A recent conference hosted by NewYork-Presbyterian Hospital/Weill ... awareness of the condition and the recent availability of treatments ...
... of the most widely used undergraduate textbook in molecular ... just been released. It incorporates the latest in ... of earlier editions that have made this a superior ... authors with outstanding teaching and research credentials, the book ...
... say ,I won,t kiss you, I,ve got a cold,. But a ... risk of passing on an infection by shaking someone,s hand than ... the United States and the UK have published the first detailed ... in hospital and healthcare settings. Their findings are published in the ...
Cached Biology News:Physician-scientists seek solutions to reproductive problems related to chromosomal variations 2Physician-scientists seek solutions to reproductive problems related to chromosomal variations 3New edition of a classic molecular biology textbook from CSHL Press and Benjamin Cummings 2If you don't want to fall ill this Christmas, then share a festive kiss but don't shake hands 2If you don't want to fall ill this Christmas, then share a festive kiss but don't shake hands 3